Veeva Systems Inc. (VEEV)
NYSE: VEEV · Real-Time Price · USD
242.00
-0.28 (-0.12%)
At close: Dec 5, 2025, 4:00 PM EST
241.15
-0.85 (-0.35%)
After-hours: Dec 5, 2025, 7:52 PM EST
Veeva Systems Revenue
Veeva Systems had revenue of $811.24M in the quarter ending October 31, 2025, with 16.02% growth. This brings the company's revenue in the last twelve months to $3.08B, up 15.96% year-over-year. In the fiscal year ending January 31, 2025, Veeva Systems had annual revenue of $2.75B with 16.20% growth.
Revenue (ttm)
$3.08B
Revenue Growth
+15.96%
P/S Ratio
12.83
Revenue / Employee
$422,472
Employees
7,291
Market Cap
39.78B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jan 31, 2025 | 2.75B | 382.95M | 16.20% |
| Jan 31, 2024 | 2.36B | 208.61M | 9.68% |
| Jan 31, 2023 | 2.16B | 304.28M | 16.44% |
| Jan 31, 2022 | 1.85B | 385.71M | 26.33% |
| Jan 31, 2021 | 1.47B | 360.99M | 32.70% |
| Jan 31, 2020 | Pro | Pro | Pro |
| Jan 31, 2019 | Pro | Pro | Pro |
| Jan 31, 2018 | Pro | Pro | Pro |
| Jan 31, 2017 | Pro | Pro | Pro |
| Jan 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
VEEV News
- 1 day ago - Veeva to Present at Upcoming Investor Conference - PRNewsWire
- 3 days ago - Why Veeva Systems' Earnings Drop Aligns With Its Long-Term Structural Weakness - Benzinga
- 3 days ago - Veeva AI Agents Now Available to Increase Productivity and Customer Centricity - PRNewsWire
- 4 days ago - 2 Growth Stocks With More Room to Run to Buy Ahead of 2026 - The Motley Fool
- 5 days ago - Veeva Systems: Unjustified Sell-Off, Justified Opportunity - Seeking Alpha
- 7 days ago - 16 software stocks for investors sifting through the bargain bin - Market Watch
- 12 days ago - Veeva Announces Expanded Partnership with Roche - PRNewsWire
- 13 days ago - Veeva Systems: Sell-Off After Q3 Results Was Justified - Seeking Alpha